Copyright
©The Author(s) 2017.
World J Dermatol. May 2, 2017; 6(2): 32-41
Published online May 2, 2017. doi: 10.5314/wjd.v6.i2.32
Published online May 2, 2017. doi: 10.5314/wjd.v6.i2.32
Patient | Age | Sex | Etiology | Extension(%) | Depth | Time to escarectomy (d) | Treated area | Predebridement dressing | Postdebridement dressing | Surgery | Time to complete healing (d) |
1 | 24 | W | Scald | 2 | DPT | 4 | Foot | SSD | Mepitel one | Yes | 35 |
2 | 31 | M | Flame | 20 | SPT and DPT | 1 | Hands and lower limbs | SSD | Mepitel one | No | 21 |
3 | 33 | M | Flame | 60 | DPT and FT | 0 | Trunk and upper limbs and foot | SSD | Mepitel one | Yes | 15 |
4 | 46 | M | Chemical | 6 | DPT and FT | 4 | Trunk | SSD | Biobrane | Yes | 19 |
5 | 90 | M | Flame | 4 | DPT and FT | 2 | Forearm and foot | SSD | Suprathel | Yes | 33 |
6 | 58 | M | Flame | 53 | DPT and FT | 0 | Hands and lower limbs | SSD | Biobrane | Yes | Exitus |
7 | 18 | W | Scald | 2 | SPT and DPT | 1 | Lower limbs | WD | Suprathel | Yes | 30 |
8 | 64 | M | Scald | 10 | MPT | 3 | Lower limbs | SSD | Suprathel | No | 14 |
9 | 58 | M | Contact | 1 | SPT and DPT | 3 | Foot | WD | Suprathel | Yes | 20 |
10 | 44 | M | Deflagration | 15 | SPT and DPT | 1 | Upper limbs | WD | Suprathel | No | 27 |
11 | 69 | M | Deflagration | 8 | SPT and DPT | 4 | Upper limbs | WD | Suprathel | No | 21 |
12 | 51 | M | Scald | 2 | SPT and DPT | 2 | Upper limbs | Nitrofurazone | Biobrane | Yes | 51 |
13 | 21 | M | Flame | 10 | SPT and DPT | 1 | Upper limbs | WD | Aquacel Ag | No | 16 |
14 | 56 | M | Flash | 5 | MPT and DPT | 4 | Hands | WD | Suprathel | No | 19 |
15 | 40 | M | Deflagration | 6 | SPT and DPT | 2 | Upper limbs | WD | SSD | No | 22 |
16 | 94 | W | Flame | 10 | DPT and FT | 4 | Trunk and upper limbs | WD | SSD | Yes | 21 |
17 | 81 | M | Flame | 2 | SPT and FT | 2 | Lower limb | WD | WD | Yes | 31 |
19 | 72 | W | Deflagration | 14 | MPT | 1 | Lower limbs | WD | Suprathel | Yes | 27 |
20 | 38 | M | Deflagration | 7 | DPT | 1 | Hands | WD | Biobrane | Yes | 38 |
21 | 63 | M | Flame | 65 | MPT and FT | 0 | Lower limbs | SSD change to WD before 24 h | Mepitel and Nitrofurazone | Yes | 23 |
22 | 46 | W | Scald | 4 | MPT | 2 | Lower limb | WD | Suprathel | No | 37 |
23 | 62 | M | Flame | 18 | SPT and DPT | 1 | Upper and lower limbs | WD | Aquacel Ag | Yes | 36 |
24 | 56 | M | Flame | 28 | SPT and DPT | 2 | Lower limbs | WD | SSD | Yes | EXITUS |
25 | 38 | W | Abrasion | 1 | DPT | 2 | Hand | WD | Aquacel Ag | No | 17 |
Wound bed | Appearance | Depression | Type of burn |
Type I | Abundance of small diameter pin-point bleeders (uniform shades of red to pink) | No | Superficial PT |
Type IIa | Sparse pattern of larger diameter bleeders (irregular shades of pink to white) | No | Mid/deep PT |
Type IIb | Sparse pattern of larger diameter bleeders (no shades, white colour) | Yes | Deep PT |
Type III | Fatty | Yes | PT |
- Citation: Palao R, Aguilera-Sáez J, Serracanta J, Collado JM, Dos Santos BP, Barret JP. Use of a selective enzymatic debridement agent (Nexobrid®) for wound management: Learning curve. World J Dermatol 2017; 6(2): 32-41
- URL: https://www.wjgnet.com/2218-6190/full/v6/i2/32.htm
- DOI: https://dx.doi.org/10.5314/wjd.v6.i2.32